迈博药业-B(02181)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02181 迈博药业-B

休市中 11-06 15:50:04

0.480

+0.000

0.00%

最高0.480	最低0.480	成交量0.00
今开0.480	昨收0.480	日振幅0.00%
总市值19.80亿	流通市值19.80亿	总股本41.24亿
成交额0.00	换手率0.00%	流通股本41.24亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02181","market":"HK","secType":"STK","nameCN":"迈博药业-B","latestPrice":0.48,"timestamp":1793951404714,"preClose":0.48,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":4124000000,"shares":4124000000,"eps":0.01,"marketStatus":"休市中","change":0,"latestTime":"11-06 15:50:04","open":0.48,"high":0.48,"low":0.48,"amount":0,"amplitude":0,"askPrice":0.48,"askSize":40000,"bidPrice":0.425,"bidSize":4000,"shortable":0,"etf":0,"ttmEps":0.023322,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":7,"adr":0,"listingDate":1559232000000,"exchange":"SEHK","adjPreClose":0.48,"openAndCloseTimeList":[[1793928600000,1793937600000],[1793941200000,1793952000000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02181","defaultTab":"news","newsList":[{"id":"1141656360","title":"迈博药业-B更新10月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1141656360","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141656360?lang=zh_cn&edition=full","pubTime":"2026-11-03 16:44","pubTimestamp":1793695447,"startTime":"0","endTime":"0","summary":"2026年11月3日，迈博药业-B（02181）披露截至2026年10月31日的月度股份变动报告。公告显示，公司注册股本继续为50,000,000,000股，面值每股0.0001美元，总注册资本5,000,000美元，与上月保持一致。截至本月末，公司已发行普通股4,124,080,000股，库存股为0股，未发生新增发行、购回或注销，公众持股量满足香港联交所相关规定。\n报告同时披露，公司的股份期权数量由上月底72,670,876份调整为72,595,684份，其中当月有75,192份期权失效；本月内并未产生因行使期权而导致的新股发行。该月报表由公司秘书曾浩贤先生签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132850875","title":"迈博药业-B 9月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1132850875","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132850875?lang=zh_cn&edition=full","pubTime":"2026-10-06 16:38","pubTimestamp":1791275900,"startTime":"0","endTime":"0","summary":"迈博药业有限公司于 2026年 10月 6日披露截至 2026年 9月 30日的证券变动月报表。公告显示，公司第 9 月末的法定/注册股本与已发行股份均无发生变动。公告显示，截至 2026年 9月 30日，公司法定/注册股本数为 50,000,000,000 股，每股面值 0.0001 美元，总额维持 5,000,000 美元不变。公告同时显示，迈博药业-B 在报告期内仍符合最低 25% 公众持股比例的相关上市规则要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168226949","title":"迈博药业-B2026年中期营收3.98亿元，经调整净利润31.36百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168226949","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168226949?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:43","pubTimestamp":1789980228,"startTime":"0","endTime":"0","summary":"根据公司公告，迈博药业-B在2026年上半年实现营收3.98亿元，对比上年同期的2.74亿元增长45.1%。公告同期披露的经调整净利润为31.36百万元，较去年同期的2.90百万元同比增长982.1%。毛利由2.41亿元增长至3.62亿元，对应毛利率约为90.9%，上年同期毛利率约为87.9%。经营活动产生的现金流量净额由4,267.1万元升至6,469.6万元，主要系本期经营业绩改善带动现金回流。其中药品销售收入约3.74亿元，居于主导地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"迈博药业-B2026年中期营收3.98亿元，经调整净利润31.36百万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136084940","title":"迈博药业-B 8月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1136084940","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136084940?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:48","pubTimestamp":1788425321,"startTime":"0","endTime":"0","summary":"2026年9月3日，迈博药业-B发布截至2026年8月31日止的证券变动月报表。报告期内，公司法定注册股本总额维持为USD 5,000,000，代表50,000,000,000股普通股，与上月末保持不变。报告期内并无新增发行或购回与注销活动，公司股本结构维持稳定。股份期权方面，根据此前股东大会于2018年8月10日通过的购股权计划，期末购股权数量为72,670,876份，与上月末持平，报告期内未发生行使、授出或失效等变动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663092029","title":"迈博药业－Ｂ(02181.HK)：中期实现纯利3136万元 同比增长982.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663092029","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663092029?lang=zh_cn&edition=full","pubTime":"2026-08-28 23:57","pubTimestamp":1787932621,"startTime":"0","endTime":"0","summary":"格隆汇8月28日丨迈博药业－Ｂ(02181.HK)公布中期业绩，截至2026年6月30日止六个月，实现营业收入人民币3.98亿元，同比增长45.1%；毛利为人民币3.62亿元，同比增长49.9%；公司拥有人应占溢利人民币3136万元，同比增长982.1%；基本每股盈利人民币0.01元。期内营业收入增加主要是因为核心产品CMAB009恩立妥?的销量在报告期内进一步增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260828/32352880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02181","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099009","title":"迈博药业-B(02181.HK)发布中期业绩 股东应占溢利3136万元 同比增长982.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099009","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662099009?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:28","pubTimestamp":1787927321,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1574","02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112844856","title":"迈博药业-B 2026年上半年财报：营收3.98亿元，经调整净利润0.31亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112844856","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112844856?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:17","pubTimestamp":1787923041,"startTime":"0","endTime":"0","summary":"迈博药业-B公布了截至2026年6月30日止六个月的财报。报告期内，营业收入约3.98亿元，同比增长45.1%。报告期内，经调整净利润0.31亿元，同比增幅982.1%。报告期内经营活动产生的现金流约0.65亿元，同比提升51.6%。报告期内，公司药品销售收入约3.74亿元，为营收的主要来源；中国内地独家推广许可权收入约0.22亿元；合约生产协议收入约0.02亿元；物料销售收入约0.00亿元。公司多款核心产品销售量保持上升，其中CMAB009恩立妥销量同比增长89.7%，CMAB008类停同比增长47.7%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"迈博药业-B 2026年上半年财报：营收3.98亿元，经调整净利润0.31亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104739968","title":"迈博药业-B公布2026年7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1104739968","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104739968?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:33","pubTimestamp":1785836014,"startTime":"0","endTime":"0","summary":"迈博药业有限公司于2026年8月4日发布了截至2026年7月31日的证券变动月报表。报告显示，截至2026年7月31日，公司法定/注册股本数量维持为50,000,000,000股，面值为每股0.0001美元，法定/注册股本总额为5,000,000美元，与上月持平。公司表示，其本月已充分符合香港联合交易所有限公司的相关公众持股量要求。截至本月末，股本结构保持不变，未出现新的发行及回购情况。根据公告信息，本月报表由公司秘书曾浩贤先生签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136371935","title":"迈博药业-B 6月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1136371935","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136371935?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:33","pubTimestamp":1783067610,"startTime":"0","endTime":"0","summary":"迈博药业有限公司于2026年7月3日提交了截至2026年6月30日的股份变动月报表。报告显示，公司6月底的注册股本仍为50,000,000,000股普通股，每股面值为0.0001美元，总注册股本5,000,000美元，与上个月持平。已发行股份总数维持在4,124,080,000股，库存股份为0股，公司表示满足联交所要求的公众持股量。截至本月末，该期权数量未发生变化，当月亦未发行新的股份或进行回购及注销操作，股本整体保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169802681","title":"迈博药业-B更新5月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1169802681","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169802681?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:36","pubTimestamp":1780389404,"startTime":"0","endTime":"0","summary":"迈博药业有限公司（股票代码：02181，股票名称：迈博药业-B）于2026年6月2日发布截至2026年5月31日的股份变动月报表。\n公告显示，公司本月底法定/注册股本仍为50,000,000,000股，面值0.0001美元，合计5,000,000美元，较上月底无变化。\n期内已发行普通股总数为4,124,080,000股，库存股为0股，均维持不变。当月未见新增发行、购回或注销情况，也无库藏股变动。\n根据报告，购股权计划当前合计72,670,876份，均为2018年8月10日股东大会通过，月内无新增授出或行使。公司亦确认符合香港联交所最低公众持股量的要求。\n本次公告由公司秘书曾浩贤先生签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518630227","title":"迈博药业-B盘中异动 下午盘股价大跌9.43%报0.480港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518630227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518630227?lang=zh_cn&edition=full","pubTime":"2025-03-11 14:02","pubTimestamp":1741672972,"startTime":"0","endTime":"0","summary":"2025年03月11日下午盘14时02分，迈博药业-B股票出现异动，股价急速跳水9.43%。截至发稿，该股报0.480港元/股，成交量2000股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出960港元。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.74%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311140252a1d44d54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311140252a1d44d54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518825121","title":"迈博药业-B股价重挫18.64% 市值跌3.69亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518825121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518825121?lang=zh_cn&edition=full","pubTime":"2025-03-10 10:01","pubTimestamp":1741572115,"startTime":"0","endTime":"0","summary":"2025年03月10日早盘10时01分，迈博药业-B股票出现波动，股价急速跳水18.64%。截至发稿，该股报0.480港元/股，成交量2万股，换手率0.00%，振幅0.00%。资金方面，该股资金流入9600港元，流出0港元。迈博药业-B股票所在的生物技术行业中，整体跌幅为0.97%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310100155a2692f93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310100155a2692f93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517972476","title":"迈博药业-B盘中异动 早盘急速上涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517972476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517972476?lang=zh_cn&edition=full","pubTime":"2025-03-06 09:40","pubTimestamp":1741225229,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时40分，迈博药业-B股票出现异动，股价快速上涨6.06%。截至发稿，该股报0.350港元/股，成交量1.6万股，换手率0.00%，振幅0.00%。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.93%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094029963b76aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094029963b76aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514360583","title":"迈博药业-B股价飙升10.00% 市值涨1.36亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514360583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514360583?lang=zh_cn&edition=full","pubTime":"2025-02-28 11:12","pubTimestamp":1740712358,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘11时12分，迈博药业-B股票出现波动，股价快速拉升10.00%。截至发稿，该股报0.330港元/股，成交量3万股，换手率0.00%，振幅0.00%。资金方面，该股资金流入9900港元，流出0港元。最近的财报数据显示，该股实现营业收入1.19亿港元，净利润-1.07亿港元，每股收益-0.02港元，毛利1.03亿港元，市盈率-5.89倍。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.25%。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228111238a25733b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228111238a25733b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514296738","title":"迈博药业-B盘中异动 临近收盘急速拉升5.26%报0.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514296738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514296738?lang=zh_cn&edition=full","pubTime":"2025-02-27 15:59","pubTimestamp":1740643171,"startTime":"0","endTime":"0","summary":"2025年02月27日临近收盘15时59分，迈博药业-B股票出现异动，股价大幅拉升5.26%。截至发稿，该股报0.300港元/股，成交量6万股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出1.8万港元。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.31%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022715593296323ad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022715593296323ad6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02181","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514008192","title":"迈博药业-B盘中异动 下午盘股价大跌8.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514008192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514008192?lang=zh_cn&edition=full","pubTime":"2025-02-26 13:43","pubTimestamp":1740548623,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘13时43分，迈博药业-B股票出现异动，股价大幅下挫8.20%。截至发稿，该股报0.280港元/股，成交量4万股，换手率0.00%，振幅0.00%。迈博药业-B股票所在的生物技术行业中，整体涨幅为2.61%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022613434398931b47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022613434398931b47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512750460","title":"迈博药业-B股价重挫21.62% 市值跌2.59亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512750460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512750460?lang=zh_cn&edition=full","pubTime":"2025-02-20 13:14","pubTimestamp":1740028454,"startTime":"0","endTime":"0","summary":"2025年02月20日下午盘13时14分，迈博药业-B股票出现异动，股价快速跳水21.62%。截至发稿，该股报0.290港元/股，成交量5万股，换手率0.00%，振幅5.41%。资金方面，该股资金流入0港元，流出1.454万港元。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，歌礼制药-B、腾盛博药-B、永泰生物-B涨幅较大，振幅较大的相关个股有腾盛博药-B、昭衍新药、永泰生物-B，振幅分别为24.19%、22.98%、22.26%。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220131414abd5b417&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220131414abd5b417&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510474876","title":"迈博药业-B盘中异动 下午盘快速跳水10.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510474876","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510474876?lang=zh_cn&edition=full","pubTime":"2025-02-11 15:04","pubTimestamp":1739257445,"startTime":"0","endTime":"0","summary":"2025年02月11日下午盘15时04分，迈博药业-B股票出现异动，股价急速下挫10.00%。截至发稿，该股报0.270港元/股，成交量4万股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出1.08万港元。迈博药业-B股票所在的生物技术行业中，整体跌幅为0.80%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211150405988152e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211150405988152e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02181","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510873421","title":"迈博药业－Ｂ(02181)股价下跌10%，现价港币$0.27","url":"https://stock-news.laohu8.com/highlight/detail?id=2510873421","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510873421?lang=zh_cn&edition=full","pubTime":"2025-02-11 15:04","pubTimestamp":1739257440,"startTime":"0","endTime":"0","summary":"[下跌股]迈博药业－Ｂ(02181) 股价在下午03:04比前收市价下跌10%，现股价为港币$0.27。至目前为止，今日最高价为$0.27，而最低价为$0.27。总成交量为4万股，总成交金额为港币$1.08万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2502111770/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2502111770/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1574","02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503312639","title":"迈博药业-B盘中异动 早盘股价大跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503312639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503312639?lang=zh_cn&edition=full","pubTime":"2025-01-13 09:50","pubTimestamp":1736733022,"startTime":"0","endTime":"0","summary":"2025年01月13日早盘09时50分，迈博药业-B股票出现波动，股价大幅下挫5.66%。截至发稿，该股报0.250港元/股，成交量10000股，换手率0.00%，振幅0.00%。迈博药业-B股票所在的生物技术行业中，整体跌幅为0.61%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113095023a21f7d15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113095023a21f7d15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02181"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mabpharm.cn","stockEarnings":[{"period":"1week","weight":0.1034},{"period":"1month","weight":-0.04},{"period":"3month","weight":0.1852},{"period":"6month","weight":0.0323},{"period":"1year","weight":-0.0769},{"period":"ytd","weight":-0.04}],"compareEarnings":[{"period":"1week","weight":0.051},{"period":"1month","weight":0.0146},{"period":"3month","weight":-0.0462},{"period":"6month","weight":-0.0724},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":-0.0448}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"迈博药业有限公司是一家主要从事癌症及自身免疫性疾病的单抗药物的研究、开发及生产的投资控股公司。该公司的主要产品包括CMAB009恩立妥（西妥昔单抗β注射液）、CMAB007奥迈舒（注射用奥马珠单抗α）、CMAB008类停（注射用英夫利西单抗）等产品。该公司的产品主要应用于结直肠癌、哮喘、荨麻疹、类风湿关节炎、成人溃疡性结肠炎等疾病。该公司还从事知识产权转让。该公司主要在中国市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.042254},{"month":2,"riseRate":0.714286,"avgChangeRate":0.036832},{"month":3,"riseRate":0.857143,"avgChangeRate":0.222845},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.093381},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.056079},{"month":6,"riseRate":0.625,"avgChangeRate":0.081525},{"month":7,"riseRate":0.375,"avgChangeRate":0.028854},{"month":8,"riseRate":0.375,"avgChangeRate":-0.038246},{"month":9,"riseRate":0.25,"avgChangeRate":-0.070492},{"month":10,"riseRate":0.375,"avgChangeRate":-0.010137},{"month":11,"riseRate":0.625,"avgChangeRate":0.015898},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.022132}],"exchange":"SEHK","name":"迈博药业-B","nameEN":"MABPHARM-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈博药业-B(02181)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈博药业-B(02181)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈博药业-B,02181,迈博药业-B股票,迈博药业-B股票老虎,迈博药业-B股票老虎国际,迈博药业-B行情,迈博药业-B股票行情,迈博药业-B股价,迈博药业-B股市,迈博药业-B股票价格,迈博药业-B股票交易,迈博药业-B股票购买,迈博药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈博药业-B(02181)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈博药业-B(02181)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}